IGFBP7 and gastric adenocarcinoma: Our thorough investigation concludes by demonstrating the crucial function of IGFBP7 in controlling the immunological milieu surrounding tumours and lactic acid metabolism, eventually leading to immunotherapy resistance in STAD.